News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health, Inc. announces initiation of clinical trial for crofelemer in rare diseases SBS-IF and MVID. First proof-of-concept results expected in H1 2025 -
-
-
COMMUNIQUÉ DE PRESSE
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
enVVeno Medical announces sustained improvements in venous disease treatment with the VenoValve one year after pivotal trial results. Pivotal trial data presented at the 37th Annual Meeting of the American Venous Forum highlights statistically significant improvements in quality of life indicators. FDA decision expected in late 2025
